Glutamate and Gamma-Aminobutyric Acid Abnormalities in Antipsychotic-Naïve Patients With Schizophrenia: Evidence From Empirical and Meta-analytic Studies Using Magnetic Resonance Spectroscopy.
Glutamate and Gamma-Aminobutyric Acid Abnormalities in Antipsychotic-Naïve Patients With Schizophrenia: Evidence From Empirical and Meta-analytic Studies Using Magnetic Resonance Spectroscopy.
复制标题
DOI:
10.1016/j.biopsych.2020.11.005
复制
发表时间:
2021-02-01
影响因子:
10.6
通讯作者:
Reid MA
中科院分区:
文献类型:
--
作者:
Reid MA
Glutamate and GABA (gamma-aminobutyric acid), the major excitatory and inhibitory neurotransmitters, respectively, play key roles in cognitive processes. Converging evidence from preclinical, postmortem, and human neuroimaging studies indicates that glutamate and GABA are involved in the pathophysiology of psychosis and schizophrenia. Antipsychotic medications used to treat schizophrenia are primarily dopamine antagonists and generally treat the positive symptoms with little effect on cognitive deficits, which can be especially debilitating and lead to poor functional outcomes. Consequently, the glutamatergic and GABAergic systems are promising targets for the development of novel medications. Magnetic resonance spectroscopy (MRS) can measure glutamate and GABA in vivo, so it is a useful tool for researchers seeking to better understand the pathophysiology of schizophrenia. In the current issue of Biological Psychiatry, original research by Bojesen et al.(1) and a meta-analysis by Kaminski et al.(2) highlight the value of MRS to further our understanding of the nature of glutamate and GABA dysfunction and cognitive deficits in schizophrenia spectrum disorders.Bojesen et al.(1) investigated the relationship between cognitive function and neurometabolites in a large group of antipsychotic-naïve patients with schizophrenia and other psychotic disorders. They used 3T MRS to measure glutamatergic metabolites in the anterior cingulate cortex (ACC) and the left thalamus as well as GABA in the ACC. They then examined associations between these metabolites and measures of attention, working memory, and premorbid intelligence. They found lower GABA in the ACC of patients with schizophrenia and psychosis, higher glutamate in the thalamus in the subgroup of patients with schizophrenia, and a positive relationship between ACC glutamate plus glutamine (Glx) and working memory in the pooled group of patients and control subjects.
登录
查看更多内容
影响因子:
5.6
作者:
Jelen, Luke A.;King, Sinead;Stone, James M.
通讯作者:
Stone, James M.
影响因子:
4.5
作者:
Tayoshi, Shin'Ya;Sumitani, Satsuki;Ohmori, Tetsuro
通讯作者:
Ohmori, Tetsuro
影响因子:
2.9
作者:
Mikkelsen M;Harris AD;Edden RAE;Puts NAJ
通讯作者:
Puts NAJ
影响因子:
10.6
作者:
Bustillo, Juan R.;Chen, Hongji;Gasparovic, Charles;Mullins, Paul;Caprihan, Arvind;Qualls, Clifford;Apfeldorf, William;Lauriello, John;Posse, Stefan
通讯作者:
Posse, Stefan
影响因子:
6.9
作者:
Bojesen KB;Ebdrup BH;Jessen K;Sigvard A;Tangmose K;Edden RAE;Larsson HBW;Rostrup E;Broberg BV;Glenthøj BY
通讯作者:
Glenthøj BY